Meet Our Experts

Digital Health – The new standard

Asthma and COPD affect over 500 million people worldwide.  Learn more from Sven Dethlefs, EVP Global Marketing & Portfolio and International Markets, as he discusses how Teva is trying to address respiratory diseases through digital health solutions.

Watch

More videos

Digital Health – The new standard

Asthma and COPD affect over 500 million people worldwide.  Learn more from Sven Dethlefs, EVP Global Marketing & Portfolio and International Markets, as he discusses how Teva is trying to address respiratory diseases through digital health solutions.

Watch

Asthma and COPD affect over 500 million people worldwide.  Learn more from Sven Dethlefs, EVP Global Marketing & Portfolio and International Markets, as he discusses how Teva is trying to address respiratory diseases through digital health solutions.

‘I’ve seen the impact that asthma and COPD can have’

Xinyu Liu develops Teva’s digital products and devices to help both patients and healthcare professionals. Here she explains why her role is an unusual one in a pharmaceutical company, why she sees her job as being an advocate for patients, and how her personal connection to asthma and COPD has fuelled her passion to work in this industry.

Watch

Xinyu Liu develops Teva’s digital products and devices to help both patients and healthcare professionals. Here she explains why her role is an unusual one in a pharmaceutical company, why she sees her job as being an advocate for patients, and how her personal connection to asthma and COPD has fuelled her passion to work in this industry.

The secret to achieving our new environmental targets? Our people

Teva has announced ambitious new environmental targets – including a long-term goal to cut greenhouse gas emissions by 33%. Richard Pickup and Ann Lee-Jeffs look behind that ambitious number to understand what it will take to achieve it.

Watch

Teva has announced ambitious new environmental targets – including a long-term goal to cut greenhouse gas emissions by 33%. Richard Pickup and Ann Lee-Jeffs look behind that ambitious number to understand what it will take to achieve it.

“Half the world’s people lack access to medicines”.

Giancarlo Francese works to help improve access to medicines for some of the world’s poorest people. His job is a challenging one: to help improve the health of millions of people – as quickly as possible. Here he discusses an important campaign to get cancer drugs to children in Malawi, and how the death of a childhood friend influenced his decision to pursue a career in the health industry.

Watch

Giancarlo Francese works to help improve access to medicines for some of the world’s poorest people. His job is a challenging one: to help improve the health of millions of people – as quickly as possible. Here he discusses an important campaign to get cancer drugs to children in Malawi, and how the death of a childhood friend influenced his decision to pursue a career in the health industry.

Biosimilars: Looking After the Little Things

Go Behind the Scenes at Teva’s state-of-the-art biopharmaceutical facility in Ulm, Germany. Discover more about biosimilars and meet the experts who are advancing more treatment options for patients.

Watch

Go Behind the Scenes at Teva’s state-of-the-art biopharmaceutical facility in Ulm, Germany. Discover more about biosimilars and meet the experts who are advancing more treatment options for patients.

A Brief History of Biopharmaceuticals

Join Teva's Steffen Nock as he takes us on a brief journey through time that charts where biopharmaceuticals came from – and where it might be going.

You may have heard of biopharmaceuticals – complex medicines made from living cells or organisms that have the potential to deliver precise and personalized treatment. Steffen Nock leads Teva’s specialty R&D department and here he charts their history, from their initial discovery in the 1890s right up to the present day.

Watch

Join Teva's Steffen Nock as he takes us on a brief journey through time that charts where biopharmaceuticals came from – and where it might be going.

You may have heard of biopharmaceuticals – complex medicines made from living cells or organisms that have the potential to deliver precise and personalized treatment. Steffen Nock leads Teva’s specialty R&D department and here he charts their history, from their initial discovery in the 1890s right up to the present day.

The Magic of Biosimilars

As Teva’s Vice President of Biologics, it's Nir Shapir’s job to oversee the creation of biopharmaceuticals, ensuring this complicated process works like a finely tuned orchestra. Go behind the scenes in our laboratory in Netanya, Israel to find out how these medicines are made.

Watch

As Teva’s Vice President of Biologics, it's Nir Shapir’s job to oversee the creation of biopharmaceuticals, ensuring this complicated process works like a finely tuned orchestra. Go behind the scenes in our laboratory in Netanya, Israel to find out how these medicines are made.

Producing Quality Products That Improve Lives

The highest quality medicines wouldn’t be of much use, though, if you couldn’t consistently deliver them when and where they’re needed most. We distribute a staggering number of products – more than 2,400 of them – on time and at a competitive price. Teva is dedicated to making lives better and healthier. Our unconditional commitment to quality and compliance is fundamental to everything we do.

Watch

The highest quality medicines wouldn’t be of much use, though, if you couldn’t consistently deliver them when and where they’re needed most. We distribute a staggering number of products – more than 2,400 of them – on time and at a competitive price. Teva is dedicated to making lives better and healthier. Our unconditional commitment to quality and compliance is fundamental to everything we do.

How do I…put patient safety first?

Patient safety is at the heart of everything we do. Join Scott behind the scenes as he shows us some of the steps taken to put patient safety first at our manufacturing sites. Teva’s medicines treat nearly 200 million people around the world every day. We know that behind every patient there is a story, a family and a struggle. These challenges inspire us to find solutions to the medical problems people face.

Watch

Patient safety is at the heart of everything we do. Join Scott behind the scenes as he shows us some of the steps taken to put patient safety first at our manufacturing sites. Teva’s medicines treat nearly 200 million people around the world every day. We know that behind every patient there is a story, a family and a struggle. These challenges inspire us to find solutions to the medical problems people face.

How do I…get dressed for work?

Getting dressed for work can be more complicated than you might think. Join Michael behind the scenes to see how he gets dressed for work when creating sterile medicines. As the world’s leading manufacturer of generic pharmaceuticals, Teva has long-established safety processes in place to create medicines in a sterile environment. Here, Michael shows us the steps he takes to make sure that patients get a quality medication that is free from contamination.

Watch

Getting dressed for work can be more complicated than you might think. Join Michael behind the scenes to see how he gets dressed for work when creating sterile medicines. As the world’s leading manufacturer of generic pharmaceuticals, Teva has long-established safety processes in place to create medicines in a sterile environment. Here, Michael shows us the steps he takes to make sure that patients get a quality medication that is free from contamination.